JANICE ENRIQUEZ: Open Payments
NPI 1952878530 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 35 payments from 12 companies in 2025. Trend: 2023 $529 · 2024 $1,529 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $312 |
| AstraZeneca Pharmaceuticals LP | 4 | $193 |
| Lilly USA, LLC | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Corcept Therapeutics | 2 | $40 |
| Exact Sciences Corporation | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Dexcom, Inc. | 2 | $35 |
| PFIZER INC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: REPATHA, BREZTRI, OTEZLA, AIRSUPRA, MOUNJARO, JARDIANCE, Korlym, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
